ITICMEDIUM SIGNALREGULATORY10-K

ITIC's filing highlights significant CFPB regulatory pullback through staff reductions and reduced enforcement activities, while showing improved profitability despite higher liabilities.

The company explicitly notes that the CFPB has "significantly cut back its supervisory and enforcement activities" through staff reductions and is facing a funding lawsuit, which could reduce regulatory pressure on ITIC's operations. This regulatory environment change, combined with new disclosure about interest rate sensitivity in their exchange services division, suggests evolving business dynamics that investors should monitor.

Comparing 2026-03-16 vs 2025-03-17View on EDGAR →
FINANCIAL ANALYSIS

ITIC showed solid operational improvement with net income rising 13.2% to $35.2M, but the company appears to be managing cash more conservatively with a 15.5% decline in cash reserves to $20.8M and reduced dividend payments falling 33.3% to $19.9M. The 15.9% increase in total liabilities to $94.8M alongside lower capital expenditures suggests either increased client deposit flows or new operational obligations, which combined with reduced cash distributions indicates management is prioritizing balance sheet flexibility over shareholder returns.

FINANCIAL STATEMENT CHANGES
Dividends Paid
Cash Flow
-33.3%
$29.9M$19.9M

Dividends cut 33.3% — significant signal of cash flow stress or capital reallocation priorities.

Capital Expenditure
Cash Flow
-25.2%
$7.4M$5.6M

Capex reduced 25.2% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Total Liabilities
Balance Sheet
+15.9%
$81.8M$94.8M

Liabilities increased 15.9% — monitor debt-to-equity ratio and interest coverage.

Cash & Equivalents
Balance Sheet
-15.5%
$24.7M$20.8M

Cash decreased 15.5% — monitor burn rate and upcoming capital needs.

Net Income
P&L
+13.2%
$31.1M$35.2M

Net income grew 13.2% — bottom-line growth signals improving overall business health.

LANGUAGE CHANGES
NEW — 2026-03-16
PRIOR — 2025-03-17
ADDED
As of February 18, 2026, there were 1,887,574 common shares of the registrant outstanding.
Given that income is derived from a portion of the interest earned on client deposits held by the Company, interest rate fluctuations may also impact the profitability of the Company s exchange services division.
During 2025, through a number of public statements and ongoing staff reductions, the CFPB has significantly cut back its supervisory and enforcement activities.
In addition, the CFPB is subject to a lawsuit regarding funding of the agency.
The Company s investment portfolio did not include any significant investments in banks, trust or insurance companies at December 31, 2025 or 2024.
+7 more — sign up free →
REMOVED
As of February 18, 2025, there were 1,885,978 common shares of the registrant outstanding.
The Company s investment portfolio did not include any significant investments in banks, trust or insurance companies at December 31, 2024 or 2023.
Treasury bills, have an original maturity of one year or less, are carried at cost, which approximates fair value due to the short duration to maturity.
EMPLOYEES AND HUMAN CAPITAL The Company and its subsidiaries had 521 full-time employees and 29 part-time employees as of December 31, 2024.
62 President, Treasurer, Chief Financial Officer, Chief Accounting Officer and Director W.
+7 more — sign up free →
MORE REGULATORY SIGNALS
BCHTHIGHBCHT has added extensive PFAS chemical definitions to their 10-K while removing ...
2026-03-31
OMERHIGHOMER achieved FDA approval for YARTEMLEA in December 2025, transforming from a c...
2026-03-31
UNCYHIGHThe FDA issued a Complete Response Letter (CRL) in June 2025 rejecting UNCY's dr...
2026-03-30
NVNOHIGHNVNO received a not-approvable letter from the FDA for its lead product VenoValv...
2026-03-26
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →